Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Feb 15, 2022
- Accession no.
- 0001209191-22-009634
- Filed
- Feb 15, 2022, 9:10 AM ET
- Trade date
- Feb 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions. Open-market purchases total $303.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +13,273 | $3.02 | +$40,018.1 | 193,684,967 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +1,259 | $3.02 | +$3,802.18 | 193,686,226 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +608 | $3.03 | +$1,839.2 | 193,686,834 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +1,701 | $3.03 | +$5,152.33 | 193,688,535 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +28,759 | $3.03 | +$87,139.77 | 193,717,294 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +11,809 | $3.04 | +$35,840.32 | 193,729,103 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +18,191 | $3.04 | +$55,300.64 | 193,747,294 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +8,200 | $3.05 | +$24,969 | 193,755,494 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +300 | $3.05 | +$915 | 193,755,794 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +12,400 | $3.06 | +$37,882 | 193,768,194 | Indirect | |
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +3,500 | $3.06 | +$10,710 | 193,771,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.